Market Research Reports

In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics) - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018

124pages
Published Date: 2013-07-31
 

Description



In vitro diagnostics provide valuable information regarding the physiological and/or pathological state of body and therefore are very essential to take well-informed medical decisions. This report estimates the market for the in vitro diagnostics terms of revenue (USD million) for the period 2012 – 2018, keeping 2011 as the base year. The in vitro diagnostics market is segmented into two major types namely market by geography and market by products. The market estimation for the U.S. and two emerging economies (China and India) have also been included in the report.

The U.S., India and China in vitro diagnostics market is segmented by products into clinical chemistry IVDs, Immunoassay IVDs, diabetes testing IVDs, blood testing IVDs, molecular diagnostics, and other IVDs. The global market for in vitro diagnostics is segmented on the basis of geography into North America, Europe, Asia-Pacific and rest of the world (RoW) regions and this market is provided in terms of USD million.

This report includes the market shares of key players in 2011. Moreover, company profiles for some of the key players are included in the report in terms of company overview, financial overview, business strategies, recent developments and product portfolio. The major companies included in the report are Abbott Laboratories Inc., Alere Inc., Bayer AG, Becton Dickinson and Company, Biomerieux SA, Beckman Coulter Inc., Danaher Corporation, Gen-Probe Incorporated, Johnson and Johnson, Life Technologies Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare (a division of Siemens AG) and Thermo Fisher Scientific Corporation.

The global in vitro diagnostics market is categorized into the following segments:
  • Market by Products
    • U.S.
      • Clinical Chemistry
      • Immunoassay
      • Diabetes Testing
      • Blood Testing
      • Molecular Diagnostics
      • Others (Flow Cytometry, Microbiological Diagnostic Techniques)
    • India
      • Clinical Chemistry
      • Immunoassay
      • Diabetes Testing
      • Blood Testing
      • Molecular Diagnostics
      • Others (Flow Cytometry, Microbiological Diagnostic Techniques)
    • China
      • Clinical Chemistry
      • Immunoassay
      • Diabetes Testing
      • Blood Testing
      • Molecular Diagnostics
      • Others (Flow Cytometry, Microbiological Diagnostic Techniques)
  • Market by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)

Table of Contents



Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Market Trend and Future Outlook
       3.1.1 Global In Vitro Diagnostics Market, 2010 – 2018 (USD Million)
3.2 Market Dynamics
       3.2.1 Market drivers
                3.2.1.1 Rising Number of Patients with Infectious and Chronic Diseases
                3.2.1.2 Increasing Global Healthcare Expenditure
                3.2.1.3 Demand for Rapid and Minimally- or Non-Invasive Diagnostic Tools & Techniques
                3.2.1.4 Impact Analysis of the Market Drivers
       3.2.2 Market Restraints
                3.2.2.1 Reimbursement Challenges Retards the Growth of Market
                3.2.2.2 Uncertain and Ambiguous Regulatory environment restrains In Vitro Diagnostics market
                3.2.2.3 Impact Analysis of the Market Restraints
       3.2.3 Market Opportunities
                3.2.3.1 Molecular Diagnostics: Key to Future
                3.2.3.2 Epigenomics-Based Diagnostics expected to be an Emerging segment in In-Vitro Diagnostic Market
       3.2.4 Porter’s Five Forces Analysis for In Vitro Diagnostic Market
                3.2.4.1 Bargaining Power of Suppliers
                3.2.4.2 Bargaining Power of Buyers
                3.2.4.3 Threat of new entrants
                3.2.4.4 Threat of substitutes
       3.2.5 Competitive rivalry
3.3 Market Attractiveness Analysis of the Global In-Vitro Diagnostics Market, by Geography

Chapter 4 Global In Vitro Diagnostics Market, by Products (Qualitative information)
4.1 Overview
4.2 Clinical Chemistry
4.3 Immunoassay
4.4 Diabetes Testing
4.5 Blood Testing
4.6 Molecular Diagnosis
4.7 Others

Chapter 5 Global In Vitro Diagnostics Market, by Geography
5.1 Overview
5.2 North America
       5.2.1 North America In Vitro Diagnostics Market, 2010-2018 (USD Million)
5.3 Europe
       5.3.1 Europe In Vitro Diagnostics Market, 2010-2018 (USD Million)
5.4 Asia Pacific
       5.4.1 Asia Pacific In Vitro Diagnostics Market, 2010-2018 (USD Million)
5.5 Rest of the World
       5.5.1 ROW In Vitro Diagnostics Market, 2010-2018 USD Million)

Chapter 6 U.S. In Vitro Diagnostics Market, by Products
6.1 Overview
6.2 Clinical Chemistry IVD Market, 2010 – 2018 (USD Million)
6.3 Immunoassay IVD Market, 2010 – 2018 (USD Million)
6.4 Diabetes Testing IVD Market, 2010 – 2018 (USD Million)
6.5 Blood Testing IVD Market, 2010 – 2018 (USD Million)
6.6 Molecular Diagnosis IVD Market, 2010 – 2018 (USD Million)
6.7 Others IVD Market, 2010 – 2018 (USD Million)

Chapter 7 China In Vitro Diagnostics Market, by Products
7.1 Overview
7.2 Clinical Chemistry IVD Market, 2010 – 2018 (USD Million)
7.3 Immunoassay IVD Market, 2010 – 2018 (USD Million)
7.4 Diabetes Testing IVD Market, 2010 – 2018 (USD Million)
7.5 Blood Testing IVD Market, 2010 – 2018 (USD Million)
7.6 Molecular Diagnosis IVD Market, 2010 – 2018 (USD Million)
7.7 Others IVD Market, 2010 – 2018 (USD Million)

Chapter 8 India In Vitro Diagnostics Market, by Products
8.1 Overview
8.2 Clinical Chemistry IVD Market, 2010 – 2018 (USD Million)
8.3 Immunoassay IVD Market, 2010 – 2018 (USD Million)
8.4 Diabetes Testing IVD Market, 2010 – 2018 (USD Million)
8.5 Blood Testing IVD Market, 2010 – 2018 (USD Million)
8.6 Molecular Diagnosis IVD Market, 2010 – 2018 (USD Million)
8.7 Others IVD Market, 2010 – 2018 (USD Million)

Chapter 9 Competitive Landscape
9.1 Global In Vitro Diagnostics Market Share, by Key Players, 2011 (%)

Chapter 10 Company Profiles
10.1 Abbott Laboratories Inc.
       10.1.1 Company Overview
       10.1.2 Financial overview
       10.1.3 Business Strategies
       10.1.4 Product Portfolio
       10.1.5 Recent Developments
10.2 Alere, Inc.
       10.2.1 Company Overview
       10.2.2 Financial Overview
       10.2.3 Business Strategies
       10.2.4 Product Portfolio
       10.2.5 Recent Developments
10.3 Bayer AG
       10.3.1 Company Overview
       10.3.2 Financial Overview
       10.3.3 Business Strategies
       10.3.4 Product Portfolio
       10.3.5 Recent Developments
10.4 Becton, Dickinson and Company
       10.4.1 Company Overview
       10.4.2 Financial Overview
       10.4.3 Business Strategies
       10.4.4 Product Portfolio
       10.4.5 Recent Developments
10.5 Biomerieux SA
       10.5.1 Company Overview
       10.5.2 Financial Overview
       10.5.3 Business Strategies
       10.5.4 Product Portfolio
       10.5.5 Recent Developments
10.6 Beckman Coulter, Inc.
       10.6.1 Company Overview
       10.6.2 Financial overview
       10.6.3 Business Strategies
       10.6.4 Product portfolio
       10.6.5 Recent developments
10.7 Gen-Probe Incorporated
       10.7.1 Company Overview
       10.7.2 Financial Overview
       10.7.3 Business Strategies
       10.7.4 Product Portfolio
       10.7.5 Recent Developments
10.8 Johnson and Johnson
       10.8.1 Company Overview
       10.8.2 Financial Overview
       10.8.3 Business Strategies
       10.8.4 Product Portfolio
       10.8.5 Recent Developments
10.9 Life Technologies Corporation
       10.9.1 Company Overview
       10.9.2 Financial Overview
       10.9.3 Business Strategies
       10.9.4 Product Portfolio
       10.9.5 Recent Developments
10.10 F. Hoffmann-La Roche Ltd
       10.10.1 Company Overview
       10.10.2 Financial Overview
       10.10.3 Business strategies
       10.10.4 Product portfolio
       10.10.5 Recent developments
10.11 Siemens Healthcare
       10.11.1 Company Overview
       10.11.2 Financial Overview
       10.11.3 Business Strategies
       10.11.4 Product Portfolio
       10.11.5 Recent Developments
10.12 Thermo Fisher Scientific, Inc.
       10.12.1 Company Overview
       10.12.2 Financial overview
       10.12.3 Business strategies
       10.12.4 Product portfolio
       10.12.5 Recent developments

List of Figures 

FIG. 1 Market Segmentation for the In Vitro Diagnostics Market
FIG. 2 Global In Vitro Diagnostics Market, U.S., 2011 (USD Million)
FIG. 3 Global In Vitro Diagnostics Market, China., 2011 (USD Million)
FIG. 4 Global In Vitro Diagnostics Market, India, 2011 (USD Million)
FIG. 5 Global In Vitro Diagnostics Market, 2010 – 2018 (USD Million)
FIG. 6 Total Healthcare Expenditure, Per Capita ( in USD)
FIG. 7 Porter’s Five Forces Analysis for In Vitro Diagnostic Market
FIG. 8 Market Attractiveness Analysis of the Microscopy Devices Market, by geography
FIG. 9 Comparative Analysis of the Global IVD Market, by Geography, 2011 & 2018 (%)
FIG. 10 N. America In Vitro Diagnostics Market , 2010 – 2018 (USD Million)
FIG. 11 Europe In Vitro Diagnostics Market, 2010 – 2018 (USD Million)
FIG. 12 Asia Pacific In Vitro Diagnostics Market, 2010 – 2018 (USD Million)
FIG. 13 RoW In Vitro Diagnostics Market, U.S., 2010 – 2018 (USD Million)
FIG. 14 Comparative Analysis of the U.S. In Vitro Diagnostics Market, by Products, 2011 & 2018 (%)
FIG. 15 Clinical Chemistry IVD Market, U.S., 2010 – 2018 (USD Million)
FIG. 16 Immunoassay IVD Market, U.S., 2010 – 2018 (USD Million)
FIG. 17 Diabetes IVD Market, U.S., Market, 2010 – 2018 (USD Million)
FIG. 18 Blood Testing IVD Market, U.S., 2010 – 2018 (USD Million)
FIG. 19 Molecular Diagnosis IVD Market, U.S., 2010 – 2018 (USD Million)
FIG. 20 Other IVD Market, U.S., 2010 – 2018 (USD Million)
FIG. 21 Comparative Analysis of the China In Vitro Diagnostics Market, by Products, 2011 & 2018 (%)
FIG. 22 Clinical Chemistry IVD Market, China, 2010 – 2018 (USD Million)
FIG. 23 Immunoassay IVD Market, China, 2010 – 2018 (USD Million)
FIG. 24 Diabetes IVD Market, China, Market, 2010 – 2018 (USD Million)
FIG. 25 Blood Testing IVD Market, China, 2010 – 2018 (USD Million)
FIG. 26 Molecular Diagnosis IVD Market, China, 2010 – 2018 (USD Million)
FIG. 27 Other IVD Market, China, 2010 – 2018 (USD Million)
FIG. 28 Comparative Analysis of the Indian In Vitro Diagnostics Market, by Products, 2011 & 2018 (%)
FIG. 29 Clinical Chemistry IVD Market, India, 2010 – 2018 (USD Million)
FIG. 30 Immunoassay IVD Market, India, 2010 – 2018 (USD Million)
FIG. 31 Diabetes testing IVD Market, India, Market, 2010 – 2018 (USD Million)
FIG. 32 Blood Testing IVD Market, India, 2010 – 2018 (USD Million)
FIG. 33 Molecular Diagnosis IVD Market, India, 2010 – 2018 (USD Million)
FIG. 34 Other IVD Market, India, 2010 – 2018 (USD Million)
FIG. 35 Global In Vitro Diagnostics Market Share, by Key Players, 2011 (%)
FIG. 36 Annual Revenue of Abbott Laboratories Inc., Diagnostics Division, 2010 – 2012 (USD million)
FIG. 37 Annual Revenue of Alere Inc., 2009– 2011 (USD million)
FIG. 38 Annual Sales of Bayer Healthcare, a division of Bayer AG, 2010–2012 (USD million)
FIG. 39 Annual revenue of BD Company,  2010 – 2012 (USD million)
FIG. 40 Annual revenue of BioMerieux SA, 2010 – 2012 (USD million)
FIG. 41 Annual revenue of Beckman Coulter, Inc., 2009 – 2010 (USD million)
FIG. 42 Annual revenue of Gen-Probe, Inc., 2010 – 2012 (USD Million)
FIG. 43 Annual revenue of Johnson and Johnson, Medical Devices an d Diagnostics Segment , 2010 – 2012 (USD Million)
FIG. 44 Annual revenue of Life Technologies Corporation, 2010 – 2012 (USD Million)
FIG. 45 Annual revenue of Roche Diagnostics, division of Roche Holdings, 2010 – 2012 (USD Million)
FIG. 46 Annual Revenue of Siemens Healthcare, 2009–2011 (USD million)
FIG. 47 (Conversion rate: 1 Euro = 1.33 USD)
FIG. 48 Annual revenue of Thermo Fisher Scientific, Inc., 2010 – 2012 (USD million)

List of Tables

TABLE 1 Market Snapshot: Global In Vitro Diagnostics Market
TABLE 2 Impact Analysis of the Market Drivers for In-Vitro Diagnostics Market
TABLE 3 Impact Analysis of the Market Restraints for Stem Cells Market
TABLE 4 Global IVD Market, by Geography, 2010 – 2018 (USD Million) 
TABLE 5 U.S. IVD Market, by Products, 2010 – 2018 (USD Million) 
TABLE 6 China IVD Market, by Products, 2010 – 2018 (USD Million) 
TABLE 7 Indian IVD Market, by Products, 2010 – 2018 (USD Million) 

Enquiry Before Buying


Free Market Analysis


In vitro diagnostic products are medical devices in the form of a reagent, kit, instrument, equipment, apparatus or system and are used either alone or in combination with other diagnostic tools for gaining critical information for health and drug/therapy monitoring. The market landscape for in vitro diagnostics is changing rapidly due to surging demand for IVDs from regions such as Asia-Pacific and Latin America. In 2011, majority share of the in vitro diagnostics market was held by North America and Europe owing to the high healthcare expenditure and structured network of clinical laboratories. However, this scenario is changing gradually since major market players in the in vitro diagnostics market are focussing on emerging economies to accelerate growth via capitalization of unmet opportunities available in these regions.

Clinical chemistry IVDs held majority of the market share in 2011, across the U.S, India and China market. However, the molecular diagnostics segment is expected to have a robust growth during the forecast period owing to their ability to detect the disease at an early stage of development. Moreover, dramatic rise in the number of diabetes patients globally is driving the diabetes testing IVDs such as blood glucose meters and glucose testing strips.

Europe followed North America in terms of market share in 2011. This market is majorly driven by the presence of strong healthcare support from public as well as private healthcare spending. Some of the other major factors which drive the in vitro diagnostics market in Europe are:
  • Rising number of infectious diseases such as pneumonia, tuberculosis, malaria, and sexually transmitted diseases, etc.
  • Aging population and the related rise in the chronic diseases such as cardiovascular diseases (CVDs), diabetes mellitus, cancer, etc.
  • Demand for advanced and automated diagnostics technologies
  • Increasing demand for the rapid diagnostics and point-of-care testing
 Significant differences in the reimbursement coverage throughout the region and the presence of ambiguous regulatory environment restraints the growth of this market. Although the healthcare system in Europe is better than many parts in the world, the increasing budgetary pressure is curbing the healthcare expenditure in this region. This is resulting into slower growth rate of in vitro diagnostics market in Europe in comparison to that of the Asia-Pacific region.

The emergence of molecular diagnostics and the epigenomics-based diagnostics are expected to drive in vitro diagnostics market in Europe. In addition, a trend of diagnostic companies collaborating with pharmaceutical companies to launch companion diagnostics will open a premium segment of in vitro diagnostics market in the near future. 

global-in-vitro-diagnostics-market-by-geography-2010-2018
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research